Science Explorer Back to mapMap
Discussion
Researcher · Abbott Fund · United States

Amanda M. Olson

Amanda M. Olson publishes mostly in Molecular Biology, Oncology and Cell Biology, on topics such as PARP inhibition in cancer therapy, DNA Repair Mechanisms and Microtubule and mitosis dynamics.

OpenAlex
World rank
#924,139
of 7,710,434 ranked researchers
Rank in United States
#304,093
of 1,627,098
Works
55
Citations
3k
Citations per work
55.4
h-index
21
i10-index 26Top 30% in Molecular Biology
Amanda M. Olson

What does Amanda M. Olson research?

Amanda M. Olson's work is mostly in Biochemistry, Genetics and Molecular Biology (38%), Medicine (22%), Immunology and Microbiology (4%).

Life Sciences: 23 works · 42.4% of their workBiochemistry, Genetics and Molecular Biology: 21 works · 38.4% of their workMolecular Biology: 16 works · 28.3% of their workCell Biology: 3 works · 6.1% of their workCancer Research: 2 works · 4.0% of their workImmunology and Microbiology: 2 works · 4.0% of their workImmunology: 2 works · 4.0% of their workEverything else: 17 works · 31.4% of their workHealth Sciences: 12 works · 22.2% of their workMedicine: 12 works · 22.2% of their workOncology: 12 works · 22.2% of their workPhysical Sciences: 2 works · 4.0% of their workChemistry: 2 works · 4.0% of their workOrganic Chemistry: 2 works · 4.0% of their workTHEIR WORKAmanda M. Olson55works
Life Sciences42%Physical Sciences4%Health Sciences22%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology2138.4%
    2. Immunology and Microbiology24.0%
  2. Everything else1731.4%
    1. Medicine1222.2%
    1. Chemistry24.0%
  1. 1Molecular Biology28% of their works
  2. 2Oncology22% of their works
  3. 3Cell Biology6% of their works
  4. 4Immunology4% of their works
  5. 5Cancer Research4% of their works
  6. 6Organic Chemistry4% of their works

Research topics

Which keywords describe Amanda M. Olson's research?

The keywords of their largest research topics: Cancer Therapy, Homologous Recombination, BRCA Mutation, PARP Inhibitors, DNA Damage, Repair, Cell Cycle and Cell Division.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 18 words, with their numbers
  1. Cancer Therapy243 topics
  2. Homologous Recombination212 topics
  3. BRCA Mutation141 topic
  4. PARP Inhibitors141 topic
  5. DNA Damage71 topic
  6. Repair71 topic
  7. Cell Cycle51 topic
  8. Cell Division51 topic
  9. DNA51 topic
  10. Microtubules51 topic
  11. Topoisomerases51 topic
  12. p5351 topic
  13. Failure Analysis41 topic
  14. HIF-141 topic
  15. Integrated Circuits41 topic
  16. Warburg Effect41 topic
  17. Enzyme Regulation31 topic
  18. Nucleotide Metabolism31 topic

Where does Amanda M. Olson work?

Amanda M. Olson's main affiliation in the publication record is Abbott Fund, United States.

How many publications and citations does Amanda M. Olson have?

OpenAlex counts 55 works and 3,046 citations for Amanda M. Olson, an h-index of 21, ranking #924,139 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Amanda M. Olson. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.